Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung

Gilberto De Lima Lopes, Joel E. Segel, Daniel S.W. Tan, Young K. Do, Tony Mok, Eric A. Finkelstein

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung'. Together they form a unique fingerprint.

Medicine & Life Sciences